Arginine deiminase originating from Lactococcus lactis ssp. lactis American Type Culture Collection (ATCC) 7962 induces G1-phase cell-cycle arrest and apoptosis in SNU-1 stomach adenocarcinoma cells

British Journal of Nutrition

Volumn 102, Issue 10, 2009, Pages 1469-1476

  Kim, Jong Eun ^a   Kim, Seo Young ^a   Lee, Ki Won ^b   Lee, Hyong Joo ^a  

^a Seoul National University   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

Apoptosis; Arginine deiminase; Cell cycle arrest; Lactic acid bacteria

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; ARGININE DEIMINASE; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; DNA; MYC PROTEIN; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME PURIFICATION; HUMAN; HUMAN CELL; IC 50; INHIBITION KINETICS; LACTIC ACID BACTERIUM; LACTOCOCCUS LACTIS; MOLECULAR CLONING; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; APOPTOSIS; CELL LINE, TUMOR; G1 PHASE; GENE EXPRESSION REGULATION; HUMANS; HYDROLASES; LACTOCOCCUS LACTIS; STOMACH; STOMACH NEOPLASMS;

LACTOCOCCUS LACTIS;

EID: 73749087025     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114509990432     Document Type: Article

References (37)

1. Gonzalez GG & Byus CV (1991) Effect of dietary arginine restriction upon ornithine and polyamine metabolism during two-stage epidermal carcinogenesis in the mouse. Cancer Res 51, 2932-2939.
2. Wu G & Morris SM Jr (1998) Arginine metabolism: nitric oxide and beyond. Biochem J 336, 1-17.
3. Wheatley DN, Scott L, Lamb J, et al. (2000) Single amino acid (arginine) restriction: growth and death of cultured HeLa and human diploid fibroblasts. Cell Physiol Biochem 10, 37-55.
4. Cheng PNM, Lam TL, Lam WM, et al. (2007) Pegylated recombinant human arginase (rhArg-peg5,000 mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion. Cancer Res 67, 309-317.
5. Gong H, Zolzer F, von Recklinghausen G, et al. (2000) Arginine deiminase inhibits proliferation of human leukemia cells more potently than asparaginase by inducing cell cycle arrest and apoptosis. Leukemia 14, 826-829.
6. Noh EJ, Kang SW, Shin YJ, et al. (2004) Arginine deiminase enhances dexamethasone-induced cytotoxicity in human T-lymphoblastic leukemia CCRF-CEM cells. Int J Cancer 112, 502-508.
7. Ensor CM, Holtsberg FW, Bomalaski JS, et al. (2002) Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo. Cancer Res 62, 5443-5450.
8. Kang SW, Kang H, Park IS, et al. (2000) Cytoprotective effect of arginine deiminase on taxol-induced apoptosis in DU145 human prostate cancer cells. Mol Cells 10, 331-337.
9. Dillon BJ, Prieto VG, Curley SA, et al. (2004) Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: a method for identifying cancers sensitive to arginine deprivation. Cancer 100, 826-833.
10. Beloussow K, Wang L, Wu J, et al. (2002) Recombinant arginine deiminase as a potential anti-angiogenic agent. Cancer Lett 183, 155-162.
11. Park IS, Kang SW, Shin YJ, et al. (2003) Arginine deiminase: a potential inhibitor of angiogenesis and tumour growth. Br J Cancer 89, 907-914.
12. Thomas JB, Holtsberg FW, Ensor CM, et al. (2002) Enzymic degradation of plasma arginine using arginine deiminase inhibits nitric oxide production and protects mice from the lethal effects of tumour necrosis factor a and endotoxin. Biochem J 363, 581-587.
13. Ascierto PA, Scala S, Castello G, et al. (2005) Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies. J Clin Oncol 23, 7660-7668.
14. Izzo F, Marra P, Beneduce G, et al. (2004) Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studies. J Clin Oncol 22, 1815-1822.
15. Kim JE, Kwon JY, Lee DE, et al. (2009) MKK4 is a novel target for the inhibition of tumor necrosis factor-a-induced vascular endothelial growth factor expression by myricetin. Biochem Pharmacol 77, 412-421.
16. Danial NN & Korsmeyer SJ (2004) Cell death: critical control points. Cell 116, 205-219.
17. Obaya AJ, Kotenko I, Cole MD, et al. (2002) The protooncogene c-myc acts through the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 to facilitate the activation of Cdk4/6 and early G1 phase progression. J Biol Chem 277, 31263-31269.
18. Perez-Roger I, Kim SH, Griffiths B, et al. (1999) Cyclins D1 and D2 mediate Myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1). EMBO J 18, 5310-5320.
19. de Moreno de LeBlanc A, Matar C & Perdigon G (2007) The application of probiotics in cancer. Br J Nutr 98, Suppl. 1, S105-S110.
20. Kim JE, Kim JY, Lee KW, et al. (2007) Cancer chemopreventive effects of lactic acid bacteria. J Microbiol Biotechnol 17, 1227-1235.
21. Kim JY, Woo HJ, Kim YS, et al. (2002) Screening for antiproliferative effects of cellular components from lactic acid bacteria against human cancer cell lines. Biotechnol Lett 24, 1431-1436.
22. Boyde TRC & Rahmatullah M (1980) Optimization of conditions for the colorimetric determination of citrulline, using diacetyl monoxime. Anal Biochem 107, 424-431. (Pubitemid 11220248)
23. Kim JE, Jeong DW & Lee HJ (2007) Expression, purification, and characterization of arginine deiminase from Lactococcus lactis ssp. lactis ATCC 7962 in Escherichia coli BL21. Protein Expr Purif 53, 9-15.
24. Vermeulen K, Berneman ZN & Van Bockstaele DR (2003) Cell cycle and apoptosis. Cell Prolif 36, 165-175.
25. Cory S & Adams JM (2002) The BCL2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2, 647-656.
26. Sasaki T, Shintani M & Kihara K (1984) Inhibition of growth of mammalian cell cultures by extracts of arginine-utilizing mycoplasmas. In Vitro 20, 369-375.
27. Feun L & Savaraj N (2006) Pegylated arginine deiminase: a novel anticancer enzyme agent. Expert Opin Investig Drugs 15, 815-822.
28. Niven CF, Smiley KL & Sherman JM (1942) The hydrolysis of arginine by streptococci. J Bacteriol 43, 651-660.
29. Kim JE, Hur HJ, Lee KW, et al. (2007) Anti-inflammatory effects of recombinant arginine deiminase originating from Lactococcus lactis ssp. lactis ATCC 7962. J Microbiol Biotechnol 17, 1491-1497.
30. Thompson CB, Bauer DE, Lum JJ, et al. (2005) How do cancer cells acquire the fuel needed to support cell growth? Cold Spring Harb Symp Quant Biol 70, 357-362.
31. Yuneva M, Zamboni N, Oefner P, et al. (2007) Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. J Cell Biol 178, 93-105.
32. Adhikary S&EilersM(2005) Transcriptional regulation and transformation by Myc proteins. Nat RevMol Cell Biol 6, 635-645.
33. Daksis JI, Lu RY, Facchini LM, et al. (1994) Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. Oncogene 9, 3635-3645.
34. Dang CV, O'Donnell KA, Zeller KI, et al. (2006) The c-Myc target gene network. Semin Cancer Biol 16, 253-264.
35. Lamb J & Wheatley DN (2000) Single amino acid (arginine) deprivation induces G1 arrest associated with inhibition of Cdk4 expression in cultured human diploid fibroblasts. Exp Cell Res 255, 238-249.
36. Leung-Pineda V, Pan Y, Chen H, et al. (2004) Induction of p21 and p27 expression by amino acid deprivation of HepG2 human hepatoma cells involves mRNA stabilization. Biochem J 379, 79-88.
37. Seo JH, Sung HJ, Choi CW, et al. (2007) Extrinsic nitric oxide donor partially reverses arginine deiminase induced cell growth inhibition through NFkB and Bcl-xL. Invest New Drugs 26, 277-282.